Your browser doesn't support javascript.
loading
Self-Organization of Sinusoidal Vessels in Pluripotent Stem Cell-derived Human Liver Bud Organoids.
Saiki, Norikazu; Nio, Yasunori; Yoneyama, Yosuke; Kawamura, Shuntaro; Iwasawa, Kentaro; Kawakami, Eri; Araki, Kohei; Fukumura, Junko; Sakairi, Tsuyoshi; Kono, Tamaki; Ohmura, Rio; Koido, Masaru; Funata, Masaaki; Thompson, Wendy L; Cruz-Encarnacion, Pamela; Chen, Ya-Wen; Takebe, Takanori.
Afiliación
  • Saiki N; Institute of Research, Tokyo Medical and Dental University (TMDU), Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
  • Nio Y; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Yoneyama Y; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Kawamura S; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Iwasawa K; Institute of Research, Tokyo Medical and Dental University (TMDU), Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
  • Kawakami E; Institute of Research, Tokyo Medical and Dental University (TMDU), Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
  • Araki K; Division of Gastroenterology, Hepatology and Nutrition & Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
  • Fukumura J; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Sakairi T; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Kono T; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Ohmura R; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Koido M; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Funata M; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Thompson WL; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Cruz-Encarnacion P; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
  • Chen YW; T-CiRA Discovery, Takeda Pharmaceutical Company Ltd, Fujisawa, Kanagawa 251-8555, Japan.
  • Takebe T; Organoid Medicine project, T-CiRA joint program, Fujisawa, Kanagawa 251-8555, Japan.
bioRxiv ; 2024 Jul 04.
Article en En | MEDLINE | ID: mdl-39005378
ABSTRACT
The induction of tissue-specific vessels in in vitro living tissue systems remains challenging. Here, we directly differentiated human pluripotent stem cells into CD32b+ putative liver sinusoidal progenitors (iLSEP) by dictating developmental pathways. By devising an inverted multilayered air-liquid interface (IMALI) culture, hepatic endoderm, septum mesenchyme, arterial and sinusoidal quadruple progenitors self-organized to generate and sustain hepatocyte-like cells neighbored by divergent endothelial subsets composed of CD32blowCD31high, LYVE1+STAB1+CD32bhighCD31lowTHBD-vWF-, and LYVE1-THBD+vWF+ cells. Wnt2 mediated sinusoidal-to-hepatic intercellular crosstalk potentiates hepatocyte differentiation and branched endothelial network formation. Intravital imaging revealed iLSEP developed fully patent human vessels with functional sinusoid-like features. Organoid-derived hepatocyte- and sinusoid-derived coagulation factors enabled correction of in vitro clotting time with Factor V, VIII, IX, and XI deficient patients' plasma and rescued the severe bleeding phenotype in hemophilia A mice upon transplantation. Advanced organoid vascularization technology allows for interrogating key insights governing organ-specific vessel development, paving the way for coagulation disorder therapeutics.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Japón